Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$0.15.

  • Angiodynamics' EPS (Basic) rose 4230.77% to -$0.15 in Q4 2025 from the same period last year, while for Nov 2025 it was -$0.67, marking a year-over-year increase of 8797.13%. This contributed to the annual value of -$0.83 for FY2025, which is 8187.19% up from last year.
  • Latest data reveals that Angiodynamics reported EPS (Basic) of -$0.15 as of Q4 2025, which was up 4230.77% from -$0.26 recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' EPS (Basic) registered a high of $1.15 during Q3 2023, and its lowest value of -$4.67 during Q1 2024.
  • Its 5-year average for EPS (Basic) is -$0.42, with a median of -$0.22 in 2021.
  • Its EPS (Basic) has fluctuated over the past 5 years, first soared by 44848.48% in 2023, then tumbled by 184583.33% in 2024.
  • Quarter analysis of 5 years shows Angiodynamics' EPS (Basic) stood at -$0.21 in 2021, then changed by 0.0% to -$0.21 in 2022, then plummeted by 242.86% to -$0.72 in 2023, then surged by 63.89% to -$0.26 in 2024, then skyrocketed by 42.31% to -$0.15 in 2025.
  • Its EPS (Basic) was -$0.15 in Q4 2025, compared to -$0.26 in Q3 2025 and -$0.15 in Q2 2025.